HOME >> BIOLOGY >> NEWS
Yale digital diagnostic technology is basis of new company, HistoRx Inc.

New Haven, Conn. -- HistoRx, Inc., a bioscience company offering novel digital technologies for in situ diagnostics developed at Yale School of Medicine, has located its operations at 25 Science Park in New Haven.

Their technology, called AQUATM (Automated Quantitative Analysis) enables researchers to localize and quantify proteins in tissue while maintaining spatial relationships -- a process that was previously impossible with conventional methods of pathology analysis and which vastly increases the quality and amount of information for analysis.

The company provides contract services to academic institutions, pharmaceutical and biotechnology companies while selectively licensing its technologies to leading academic and research laboratories.

"HistoRx is a great example of the continuing effort of Yale University to expand the biotechnology industry in the New Haven area," said Jon Soderstrom, managing director of the Office of Cooperative Research at Yale.

HistoRx has exclusive license to the AQUATM technology developed by two of the company's founders, David Rimm, M.D., and Robert Camp, M.D., both in the Department of Pathology at Yale. HistoRx also holds exclusive license to databases from Yale's tissue archive containing 20- to 40-year clinical follow up information corresponding to different types of human cancer. The School of Medicine's archive holds more than three million tissue samples collected over the past 70 years.

Robert Curtis, president, CEO and co-founder of HistoRx, said, "The company is grounded in the firm belief that the power of AQUATM, coupled with the extensive clinical data of the Yale tissue archive, provides an extraordinary new tool for substantial improvement in tissue analysis both
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
20-Sep-2004


Page: 1 2

Related biology news :

1. New study to compare digital, film mammography in massive $26.5 million effort to save womens lives
2. Hopkins selected to participate in first major study of digital mammography
3. Undergrads digital model of amoeba helps scientists study human cells
4. Johns Hopkins experts launch Palm OS version of digital antibiotics and infectious disease guide for physicians
5. Research shows radiologists will need different programs for digital mammography to work best
6. Pre-delivery digital exams may increase in utero bacterial levels
7. New diagnostic technology helps justify earlier cataract surgery
8. New diagnostic tool brings effective treatment closer to patients
9. Nanoparticle probes are destined for major new role in medical diagnostics and drug delivery
10. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
11. Worlds leading mad cow diagnostic company, responds to USDAs additional BSE protection measures

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical (ABM), a leading ... for not only the products and treatments developed, but also the dedicated team ... All the brands built by ABM have received several honors already for 2020, ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... B.V. (MBS) has announced a publication detailing the use of its revolutionary ... polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure ... for glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of ... Fellows are charged with supporting the organization’s initiatives and overall vision. , "Senior ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... of Technology (MIT) has expanded the company’s exclusive license to include clinical ... the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a ... of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. ... lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine ...
(Date:7/7/2020)... , ... July 06, 2020 , ... ... Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts ... Bio-IT World has hosted an elite awards program, highlighting outstanding examples of how ...
Breaking Biology Technology:
Cached News: